George K. Ng

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
8 years
Director since
2023

8 years of board service in total across 3 boards, counting each seat separately. Longest: Calidi Biotherapeutics Inc., 3 years.

3 years · Since 2023
Processa Pharmaceuticals Inc. Director · Chief Executive Officer
2 years · Since 2023
1 year · Since 2024

Chief executive roles

Processa Pharmaceuticals Inc. · Chief Executive Officer
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 8, 2026 Processa Pharmaceuticals Inc. Option exercise +1,600 — —
Jul 1, 2026 Processa Pharmaceuticals Inc. Open-market purchase +3,057 $1.93 $5,900
Jun 15, 2026 Processa Pharmaceuticals Inc. Open-market purchase +2,465 $2.22 $5,472
May 29, 2026 Processa Pharmaceuticals Inc. Open-market purchase +2,129 $2.57 $5,472
May 15, 2026 Processa Pharmaceuticals Inc. Open-market purchase +1,843 $2.97 $5,474
Apr 30, 2026 Processa Pharmaceuticals Inc. Open-market purchase +2,034 $2.69 $5,471
Apr 15, 2026 Processa Pharmaceuticals Inc. Open-market purchase +1,843 $2.97 $5,474
Mar 31, 2026 Processa Pharmaceuticals Inc. Open-market purchase +2,136 $2.54 $5,425
Jan 27, 2025 Processa Pharmaceuticals Inc. Open-market purchase +87,200 $0.80 $69,760
Jan 30, 2024 Processa Pharmaceuticals Inc. Open-market purchase +10,000 $2.70 $27,000
Oct 12, 2023 Processa Pharmaceuticals Inc. Grant or award +100,000 $0.25 $25,000
Oct 10, 2023 Processa Pharmaceuticals Inc. Grant or award +100,000 $0.25 $25,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.